Axel Hauschild

8PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPattern recognitionHaematological tumoursDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 04, 2023
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma.

Alexander Cj van Akkooi, Axel Hauschild, Georgina V Long

|Jul 13, 2021
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review.

Julia Höhn, Achim Hekler, Eva Krieghoff-Henning

|May 01, 2021
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS.

R Gutzmer, H-J Schulze, A Hauschild

|Feb 02, 2021
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study.

Max Schmitt, Roman Christoph Maron, Achim Hekler

|Sep 11, 2020
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study.

Roman C Maron, Jochen S Utikal, Achim Hekler

Pageof 2